Clinical Study
Rebamipide Improves Chronic Inflammation in the Lesser Curvature of the Corpus after Helicobacter pylori Eradication: A Multicenter Study
Table 2
Comparison of histological gastritis before and after H. pylori eradication in the rebamipide group.
| | | Before eradication | After eradication | value |
| GC of the middle antrum | Activity | 1.00 ± 0.12 (48) | 0.00 ± 0.00 (47) | <0.0001 | Inflammation | 2.44 ± 0.10 (48) | 1.21 ± 0.08 (47) | <0.0001 | Atrophy | 1.27 ± 0.07 (48) | 0.96 ± 0.10 (47) | 0.0270 | Intestinal metaplasia | 0.69 ± 0.16 (48) | 0.43 ± 0.11 (47) | 0.0887 |
| GC of the middle corpus | Activity | 1.08 ± 0.11 (49) | 0.02 ± 0.01 (47) | <0.0001 | Inflammation | 2.24 ± 0.09 (49) | 1.11 ± 0.10 (47) | <0.0001 | Atrophy | 0.90 ± 0.09 (49) | 0.34 ± 0.08 (47) | <0.0001 | Intestinal metaplasia | 0.14 ± 0.09 (49) | 0.19 ± 0.09 (47) | 0.5039 |
| LC of the middle corpus | Activity | 1.00 ± 0.11 (48) | 0.00 ± 0.00 (49) | <0.0001 | Inflammation | 2.29 ± 0.10 (48) | 1.12 ± 0.08 (49) | <0.0001 | Atrophy | 1.17 ± 0.09 (48) | 0.71 ± 0.10 (49) | 0.0005 | Intestinal metaplasia | 0.85 ± 0.17 (48) | 0.84 ± 0.16 (49) | 0.6950 |
|
|
Data are presented as mean ± standard error (). GC: greater curvature and LC: lesser curvature.
|